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Consideration of Cognitive Behavioral Therapy in Treating Schizophrenia: An Evidence-
Based Practice Project 
Kati Boucher, BA, RN Mentor: Linda Samia, PhD, RN 
Purpose:  
to answer the clinical PICOT question: For patients with 
schizophrenia how does CBT (cognitive behavioral therapy) 
and medication management compare to medication 
management alone affect symptom severity 
Background: 
• Schizophrenia is a debilitating psychological condition that 
affects 8 out of every 1000 individuals in the US, the 
etiology is unknown and believed to be partially related to 
genetics, and substance abuse.  
• CBT is the utilization of therapy to reorganize thought 
content, challenge core beliefs, recognize and implement 
coping strategies, reframes negative experience and 
introduces structure.  
• CBT has been recognized as an effective treatment for the 
management of a variety of psychiatric illnesses as a 
means of changing perceptions, behaviors, and teaching 
coping skills. 
• The NIH (National Institute of Mental Health) indicates 
antipsychotic medications as the primary treatment for 
schizophrenia. Therapy is not included in this guideline 
established by the NIH. 
• The trajectory for schizophrenia includes relapse and 
hospitalizations into the course of the disease.  
  
Methods 
• Databases Searched: PsychArticles, PsychInfoNet, Medline, 
CINAHL, EBSCO. 
• Keywords: Schizophrenia, Psychosis, CBT, Therapy.  
• Inclusion criteria: RCT's, meta-analysis, Cross sectional 
cohort study, Controlled trials without randomization 
published between 2007-2017. Adults.  
• Exclusion Criteria: Articles not specific to Schizophrenia, 
not specific to CBT. In a language other than English. PTSD, 
co-occurring and substance abuse, Autism spectrum 
disorders. 
• Final sample:  1 meta-analysis, 2 RCT's, 2 Cross sectional 
cohort studies.  
Proposed Evaluation:  
• Measure pre/post provider knowledge and attitudes 




• Schizophrenia is debilitating and a chronic mental illness that 
needs additional supports.  
• Symptom improvement does not equate to prevention of 
relapse and hospitalization. 
• The goal of treatment is to improve functioning and relieve 
suffering. 
• Providers need to be discussing the benefits of additional 
treatments with their psychotic patients. 
References 
1. Erickson, D. et al. Cognitive-behaviour therapy for medication-resistant positive symptoms in early psychosis: a case series. Early Intervention in Psychiatry. (2010) 4: 251-256 
2. Kennedy, L. et al. Cognitive behaviooral Therapy Compared with Non-specialized Therapy for Alleviating the Effect of Auditory Hallucinations in people with Reoccurring Schizophrenia: A 
systematic Review and Meta-analysis. Community Mental Health J. (2017) 53: 127-133 
3. Perry, Y et al. The development and implementation of a pilot CBT for early psychosis service: achievements and challenges. Early intervention in Psychiatry (2015) 9: 252-259 
4. Lincoln, T. et al. Moving from efficacy to effectiveness in cognitive behavioral therapy for psychosis: a randomized clinical practice trial. Journal of consulting and clinical psychology. (2012) Vol 
80, No. 4, 674-686. 
5. Tarrier, N. Two-year follow-up of cognitive-behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical 
Psychology. (2000) Vol 68, No. 5, 917-922 
Evidence Synthesis:  
• There was no difference found between CBT and supportive 
therapy, both were effective in reducing positive symptoms 
(hallucinations, delusions) compared to control groups. 2,4,5 
• In 2 of the 5 studies, where a control group was not utilized, 
end results were compared to pretherapy results. Both of 
these studies indicated CBT was effective for reducing 
positive and negative symptoms. 1,3 
• One article with a longitudinal design supported therapy as a 
beneficial treatment 2 years after treatment ended. 5 
• This evidence indicates that therapy should be a 
recommended adjunctive treatment for psychosis.  The type 
of therapy utilized by the therapist was not statically 
significant. 
• The evidence suggests that patients with a psychotic disorder 
do better with additional supports.  
• One study where hospitalizations were included as a measure 
of success demonstrated that improved symptoms did not 
prevent future hospitalization. It did lengthen the time 
between readmissions for the therapy cohort. 5 
Translation to Practice 
• The first step to increasing therapy referrals is to change the 
culture for patients and providers, teaching that therapy is 
effective, patients need to understand the benefit of 
additional services. 
• Provide an in-service presentation for providers highlighting 
the available research comparing CBT to control groups.  
• Inform patients of the benefits of therapy. Provide 
informational flyers in an outpatient office.  
• Encourage providers to discuss the benefits of adjunctive 
therapy with their patients diagnosed with schizophrenia..  
• There are no known side effects for recommending therapy.  
 
